 | Up a level |
Van Bulck, Liesbet; Kovacs, Adrienne H; Goossens, Eva; Luyckx, Koen; Zaidi, Ali; Wang, Jou-Kou; Yadeta, Dejuma; Windram, Jonathan; Van De Bruaene, Alexander; Thomet, Corina; Thambo, Jean-Benoît; Taunton, Marshall; Sasikumar, Navaneetha; Sandberg, Camilla; Saidi, Arwa; Rutz, Tobias; Ortiz, Lucia; Mwita, Julius Chacha; Moon, Ju Ryoung; Menahem, Samuel; ... (2022). Rationale, design and methodology of APPROACH-IS II: International study of patient-reported outcomes and frailty phenotyping in adults with congenital heart disease. International journal of cardiology, 363, pp. 30-39. Elsevier 10.1016/j.ijcard.2022.06.064
Male, Christoph; Lensing, Anthonie W A; Palumbo, Joseph S; Kumar, Riten; Nurmeev, Ildar; Hege, Kerry; Bonnet, Damien; Connor, Philip; Hooimeijer, Hélène L; Torres, Marcela; Chan, Anthony K C; Kenet, Gili; Holzhauer, Susanne; Santamaría, Amparo; Amedro, Pascal; Chalmers, Elizabeth; Simioni, Paolo; Bhat, Rukhmi V; Yee, Donald L; Lvova, Olga; ... (2020). Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. The Lancet. Haematology, 7(1), e18-e27. Elsevier 10.1016/S2352-3026(19)30219-4
